About
Sophie is a London-based, US-qualified associate in our Global Transactions team.
She primarily focuses on representing issuers and underwriters in connection with equity and debt capital markets transactions.
Sophie has experience advising on transactions in the UK, Europe, and the Middle East.
Additional Information
- Advising CVC in connection with the sell-down of Zabka shares in November 2025
- Advising Dubizzle on its proposed IPO in 2025 on the Dubai Financial Market
- Advising Unicredit on its proposed takeover of Banco BPM in 2025
- Advising HBX Group International on its 2025 IPO on the Barcelona, Bilbao, Madrid and Valencia Stock Exchanges
- Advising Cenergy Holdings SA on its €200 million capital increase by way of a public offer in Belgium and Greece and private placements in various jurisdictions
- Advising Aston Martin Lagonda on its £111 million non-pre-emptive equity placing in 2024
- Advising CVC in connection with the sell-downs of Synsam shares in 2024 and 2025
- Advising Sanofi on the separation and spin-off of Opella, its consumer healthcare business
- Advising AstraZeneca on its collaboration and investment agreement with Cellectis
Sophie Desch
Associate
London Office
100 Bishopsgate
London EC2P 2SR